When was Cellivate Technologies founded?

Cellivate Technologies was founded in 2019 and raised its 1st funding round 4 years after it was founded.

Where is Cellivate Technologies located?

Cellivate Technologies is headquartered in Singapore, Singapore. It is registered at ROBINSON ROAD, Singapore, 68914.

Who is the current CEO of Cellivate Technologies?

Viknish Krishnan-Kutty of Cellivate Technologies. They have also founded 2 companies.

Which legal entities is Cellivate Technologies associated with?

Cellivate Technologies is associated with CELLIVATE TECHNOLOGIES PTE. LTD..

How many employees does Cellivate Technologies have?

As of Oct 31, 2026, the latest employee count at Cellivate Technologies is 9.

Is Cellivate Technologies a funded company?

Cellivate Technologies is a funded company, having raised a total of $2.02M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 08, 2023.

When was the latest funding round of Cellivate Technologies?

Cellivate Technologies' latest funding was a $***** Seed round on Apr 2025, with participation from 1 investor.

What is the annual revenue of Cellivate Technologies?

Annual revenue of Cellivate Technologies is less than SGD 1M as on Dec 31, 2024

Where does Cellivate Technologies rank among its competitors?

Cellivate Technologies ranks 3rd amongst 22 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Cellivate Technologies, which secured an undisclosed amount in Apr, 2025.

Who are the top competitors of Cellivate Technologies?

Cellivate Technologies' top competitors include Multus, Nu-Tek Biosciences and Metatissue. Among them, Cellivate Technologies secured the most recent funding round in April, 2025.

Cellivate Technologies - 2026 Company Profile, Team, Funding, Competitors & Financials

Cellivate Technologies is a seed company based in Singapore (Singapore), founded in 2019 by Viknish Krishnan-Kutty. It operates as a Developer of nanotechnology to study issues related to growing cells. Cellivate Technologies has raised $2.02M in funding from Antler. The company has 22 active competitors, including 3 funded and 2 that have exited. Its top competitors include companies like Multus, Nu-Tek Biosciences and Metatissue.

Company Details

Developer of nanotechnology to study issues related to growing cells. It offers a product called ProCYTE, which is designed to improve cell growth and adhesion. It caters to biotechnology.

Website: www.cellivatetech.com/
Social
Email ID: *****@cellivatetech.com
Phone Number: +65 **********
Registered Address: ROBINSON ROAD, Singapore, 68914

Key Metrics

Founded Year

2019

Location

Singapore, Singapore

Stage

Seed

Total Funding

$2.02M in 4 rounds

Latest Funding Round

Seed, Apr 2025, $*****

Investors

Antler & 5 more

Ranked

3^rd among 22 active competitors

Annual Revenue

SGD 0 - 1M as on Dec 31, 2024

Employee Count

9 as on Oct 31, 2026

Similar Companies

Multus & 21 more

View Cellivate Technologies' full profile

Cellivate Technologies is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
CELLIVATE TECHNOLOGIES PTE. LTD. UEN: 201933761H , Singapore, Active	Oct 08, 2019	SGD 0 - 1M (As on Dec 31, 2024)	-

Cellivate Technologies has raised a total funding of $2.02M over 4 rounds. Its first funding round was on May 08, 2023. Its latest funding round was a Seed round on Apr 2025 for $*****. 1 investor participated in its latest round. Cellivate Technologies has 6 institutional investors.

Here is the list of recent funding rounds of Cellivate Technologies:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 2025	4663367	Seed	5463606	3378783	7124445	2854827
Jan 27, 2025	2967605	Seed	4856013	3007858	2842435	We Founder Circle
Aug 06, 2024	4385098	Seed	6645790	4474218	Antler	Venture Catalysts & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Cellivate Technologies's funding rounds and investors

The founders of Cellivate Technologies is Viknish Krishnan-Kutty. Viknish Krishnan-Kutty is the CEO of Cellivate Technologies.

Here are the details of Cellivate Technologies' key team members:

Viknish Krishnan-Kutty: Founder & CEO of Cellivate Technologies and founder of 2 other companies, ProjectEx Lab and Cellivate Technologies.
Contact Info: 1 email address

View details of Cellivate Technologies's Founder profiles and Board Members

Cellivate Technologies' employee count trend

Cellivate Technologies has 9 employees as of Oct 26. Here is Cellivate Technologies's employee count trend over the years:

Employee count trend for Cellivate Technologies

Uncover Cellivate Technologies' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cellivate Technologies include Multus, Nu-Tek Biosciences and Metatissue. Here is the list of Top 10 competitors of Cellivate Technologies, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Multus 2019, London (United Kingdom), Series A	Provider of lab-grown meat alternatives	$9.3M	SOSV, Big Idea Ventures & 26 others	45/100
2nd	Nu-Tek Biosciences 2008, Minnetonka (United States), Unfunded	Developer of animal-free peptones and cell culture media for pharmaceutical applications	-	-	43/100
3rd	Cellivate Technologies 2019, Singapore (Singapore), Seed	Developer of nanotechnology to study issues related to growing cells	$2.02M	Venture Catalysts, We Founder Circle & 4 others	37/100
4th	Metatissue 2018, Ilhavo (Portugal), Funding Raised	Provider of human protein-based products for cell culture, tissue engineering, and disease modeling applications	-	Europa	27/100
5th	Edge 2021, New York City (United States), Unfunded	Provider of stem cell technology products for agriculture, life sciences, and cosmetics	-	-	27/100
6th	Onkologic 2021, Farmington (United States), Seed	Developer of NK cell culture media for cell therapies	$305K	-	25/100
7th	Cellular Engineering Technologies 2000, Coralville (United States), Early Stage	Provider of cell lines to help researchers and process development professionals	$45K	HHS	25/100
8th	Nano3D Biosciences 2008, Houston (United States), Unfunded	Proprietary magnetic 3D cell culture	-	-	24/100
9th	Alt Biotech 2023, Evry Courcouronnes (France), Unfunded	Provider of cell-culture for production of non-therapeutics recombinant protiens	-	-	24/100
10th	Sarvoshadhi Bio 2017, Kolhapur (India), Funding Raised	Developer of products and solutions related to cell culture media and biotechnology	-	BIRAC	24/100